Floatz logo

r-5780

Adenoma

Rise Therapeutics LLCPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Adenoma cohort.

Asset / SponsorPhaseRating
Folic Acid
US Department of Veterans Affairs
Phase 2B
S-Adenosyl-L-Methionine
Jun Gong, MD
Phase 1CC
Eovist
Bayer
D
BAY-86-4873
Bayer
D

Same molecule, other indications

r-5780 is also rated in:

skin squamous cell carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
Solid Tumor, AdultDormant
C
Indicative ·
37 / 100
View asset →
melanomaDormant
C
Indicative ·
37 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →